ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1362	National Cancer Institute	Html	en	Hot Flashes and Night Sweats (PDQ®)–Health Professional Version	Expert-reviewed information summary about causes and treatment of hot flashes and night sweats in cancer patients.	hot flash scores 0.45918 tamoxifen-induced hot flashes 0.487401 Loprinzi CL 0.545839 menopausal symptoms 0.464059 Barton DL 0.475444 nocturnal hot flashes 0.494473 black cohosh 0.488248 androgen deprivation therapy 0.448869 clinical trial 0.448391 breast cancer treatment 0.460098 breast cancer patients 0.474226 postmenopausal breast cancer 0.456276 hot flashes merits 0.487946 Natl Cancer Inst 0.459556 breast cancer survivors 0.509665 North Central Cancer 0.472407 hot flash reduction 0.458714 hot flashes 0.905213 hormone replacement therapy 0.476539 et al. 0.506432 women 0.50642 core body temperature 0.45737 night sweats 0.457026 study 0.456946 stage breast cancer 0.454333	hot flash studies 0.449594 hot flushes 0.465978 breast cancer diagnosis 0.451556 postmenopausal hot flashes 0.500892 breast cancer recurrence 0.47207 hot flash management. 0.448239 PUBMED Abstract 0.549613 Cancer Res Treat 0.462211 nighttime hot flashes 0.501942 hot flash frequency 0.50736 menopausal hot flashes 0.487616 Cancer Treatment Group 0.476248 hot flash management 0.49365 postmenopausal women 0.477394 breast cancer risk 0.486953 Clin Oncol 0.505954 receptor–positive breast cancer 0.451466 breast cancer 0.743246 randomized controlled trial 0.545918 hot flash 0.591793 healthy postmenopausal women 0.454945 prostate cancer 0.455636 placebo-controlled trial 0.450402 Central Cancer Treatment 0.476295	CLICK HERE
1375	National Cancer Institute	Html	en	Cancer Screening Overview (PDQ®)–Health Professional Version	Information about measuring the effectiveness of cancer screening tests and about weighing the strength of the evidence obtained from cancer screening research studies.	PDQ Screening 0.435302 cancer antigen 0.351044 cancer screening interventions 0.511292 advanced-stage pancreatic cancer 0.361147 cancer screening 0.938139 lung cancer screening 0.519031 new screening test 0.500274 cancer prevention 0.350991 Interval cancer events 0.364348 new screening modality 0.453389 IIIB–IV lung cancer 0.361117 prostate screening 0.417963 lung cancer rates 0.355466 prostate cancer treatment 0.3549 mammography screening 0.457867 screening program 0.415447 screening summaries 0.435473 disease-specific mortality 0.409334 cancer cases 0.346604 whole-body screening technologies 0.500642 lower cancer risk 0.359738 interval cancer rates 0.358328 colorectal cancer 0.351483 routine cancer screening 0.555956	recent screening 0.436851 false-negative screening test 0.511207 older screening modalities 0.448481 breast cancer 0.418358 cancer diagnosis 0.374736 prostate cancer screening 0.551218 actual cancer risk 0.422669 cancer screening tests 0.659235 randomized controlled trial 0.36573 prostate cancer mortality. 0.348853 false-positive screening results 0.509129 screening center 0.444606 fecal occult blood 0.356414 higher cancer risk 0.360321 cancer mortality. 0.353113 decision making 0.410621 all-cause mortality 0.362129 breast cancer overdetection 0.35093 routine screening mammographies 0.474709 randomized clinical trials 0.34952 Cancer Screening Trial 0.566983 invasive diagnostic procedures 0.355819 routine PSA screening 0.472621	CLICK HERE
1452	National Cancer Institute	Html	en	Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Health Professional Version	Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.	smoking cessation strategy 0.633721 smoking cessation rates 0.605741 quit attempt 0.552085 effective smoking cessation 0.580922 gradual cessation group 0.483049 abrupt cessation 0.562882 prolonged validated smoking 0.480554 lung cancer 0.658405 tobacco cessation 0.463262 smoking cessation pharmacotherapies 0.597527 abrupt smoking cessation 0.601297 pipe tobacco smoking 0.505275 current smoking 0.475722 gradual cessation arm 0.465437 nicotine replacement therapy 0.54532 randomized trial 0.492165 Smoking cessation counseling 0.609156 receptor partial agonist 0.460896 area-level smoking prevalence 0.513667 smoking reduction 0.49426 smoking behavior 0.469981 smoking cessation treatment 0.588411 smoking prevalence data 0.513642 tobacco products 0.485537	abrupt cessation arm 0.472163 smoking cessation 0.926558 vs abrupt cessation 0.475821 adult cigarette smoking 0.474818 gradual cessation method 0.466403 cigarette smoking cessation 0.573293 cigarette smoking 0.62168 smoking cessation pharmacotherapy 0.595082 varenicline 0.542592 tobacco smoking 0.505702 smoking cessation rate. 0.602815 gradual cessation 0.501212 abrupt cessation group 0.489713 nicotinic acetylcholine receptor 0.464069 self-reported smoking abstinence 0.502629 smoking abstinence 0.574891 cigarette smoking prevalence 0.566333 randomized controlled trial 0.482431 6-month cessation rates 0.474432 nicotine patch 0.531368 smoking cessation intervention 0.590903 usual smoking patterns 0.480697 lung cancer mortality 0.510576 varenicline group 0.534998	CLICK HERE
1682	National Cancer Institute	Html	en	Family Caregivers in Cancer: Roles and Challenges (PDQ®)–Health Professional Version	Expert-reviewed information summary about the challenges faced by family caregivers of cancer patients. This summary focuses on typical caregiver roles and concerns, and helpful interventions for caregivers.	caregiver strain 0.637562 caregiver self-efficacy 0.583778 caregiver involvement 0.610915 cancer care facility 0.578352 palliative care consultation 0.608288 caregiver knowledge 0.586068 Hispanic caregivers 0.676204 caregiver 0.821035 Caregiver quality 0.603509 white caregivers 0.639176 health care providers 0.59721 specialist-level palliative care 0.56948 caregiver well-being 0.592799 patient symptom care 0.583377 culturally competent care 0.564531 patients 0.715455 cancer patients 0.703941 Asian American caregivers 0.689382 caregiver emotional health 0.625075 secondary informal caregivers 0.653486 caregiver burden 0.63516 caregiver’s information 0.595277 symptom management 0.696609 orient caregivers 0.633121 primary caregiver 0.613245	caregiver portion 0.581896 African American caregivers 0.664952 caregiver needs 0.592313 end-of-life care 0.586635 family caregivers 0.726566 study 0.578902 problem-solving intervention 0.564815 bereaved caregivers 0.642182 palliative care 0.6279 tailored caregiver interventions. 0.613747 African American patients 0.595756 caregivers 0.977146 terminally ill patients 0.564522 studies 0.568233 empowers caregivers 0.628512 caregiver roles 0.620453 minority caregivers 0.663649 emotional support 0.572233 home care workers 0.567134 Caregivers report 0.630818 Caregiver assessment 0.592589 family caregiver 0.60516 cancer patient 0.576832 difficult caregiver responsibilities 0.601191	CLICK HERE
1790	National Cancer Institute	Html	es	Trastornos del sueño (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las causas y manejo de los trastornos del sueño en las personas con cáncer.	menudo causa problemas 0.738807 TCC ayuda 0.533662 pequeño número 0.542064 siguientes aspectos 0.690699 siguientes elementos 0.547894 leucemia linfocítica aguda 0.539982 sudores nocturnos 0.6269 siguientes cambios 0.544948 menor número 0.522208 Frecuencia respiratoria 0.534403 fase monr 0.549571 salud afectarán 0.52618 National Cancer Institute 0.522679	sueño mejora 0.68532 siguientes riesgos 0.520223 sueño mor 0.930755 Instituto Nacional 0.543079 siguientes problemas 0.588617 siguientes funciones 0.571878 Physician Data Query 0.591028 fase mor 0.552867 PDQ Trastornos 0.547079 auto hipnosis 0.530427 numerosas razones 0.546303 solo relajarme 0.534672	CLICK HERE
2105	National Cancer Institute	Html	es	Exámenes de detección del cáncer de endometrio (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de endometrio.	Surgical Adjuvant Breast 0.318516 Obstet Gynecol 0.462808 endometrial neoplasia 0.330318 endometrial carcinoma 0.35462 mujeres asintomáticas conducirán 0.327753 endometrial biopsy 0.375747 Society Cancer Detection 0.324775 Sin embargo 0.322994 American Cancer Society 0.532275 Barakat RR 0.322448 postmenopausal estrogen 0.311047 Hereditary nonpolyposis colon 0.316803 Cancer Society Guidelines 0.326353 mutation analysis 0.309345 CA Cancer 0.344524 ecografía transvaginal 0.32543 Instituto Nacional 0.316776 PDQ Exámenes 0.310268 Natl Cancer Inst 0.409601 Vasen HF 0.314679 Bowel Project P-1 0.314149 Survival analysis 0.309166 endometrial thickness 0.328405 Gynecol Oncol 0.319248 patients with 0.312917	endometrial cancer 0.986652 Endometrial morphology 0.328059 Genetics Studies Consortium 0.313592 Cancer Facts 0.328027 Cancer risk 0.385512 with endometrial biopsy 0.334209 mutation carriers 0.308983 Cancer Survival Study 0.330775 hereditary nonpolyposis 0.373835 National Cancer Institute 0.323419 endometrial biopsy specimens 0.329768 replacement therapy 0.315579 postmenopausal women 0.352328 Clin Oncol 0.321066 Gynaecol Obstet 0.310774 PDQ Genetics 0.309874 mujeres portadoras 0.322212 adjuvant breast 0.320298 ecografía endovaginal 0.333573 endometrial abnormalities 0.37706 National Surgical Adjuvant 0.314342 Ultrasound Obstet Gynecol 0.310185 mujeres morirán 0.321645 Mecklin JP 0.317214	CLICK HERE
3523	National Cancer Institute	Html	es	Estudio NCI-MATCH (Análisis Molecular para Selección de Tratamientos)	Información sobre el estudio del NCI: Análisis Molecular para Selección de Tratamientos (NCI-MATCH), en el cual los investigadores examinarán tejidos de tumor de pacientes con tumores sólidos y linfomas avanzados que han dejado de responder al tratamiento.	Tumor Profiling 0.554625 estudio match 0.941659 Investigación Oncológica 0.6022 MD Anderson 0.61416 Memorial Sloan-Kettering Cancer 0.578519 Clinical Trials 0.539697 posibles participantes 0.607033 C2 MET 0.546519 Life Sciences 0.627896 laboratorios foundation medicine 0.56991 Foundation Medicine 0.623082 Memorial Sloan-Kettering identificarán 0.577406 estudio comet 0.807536 Grupo Cambio 0.537516 met amp crizotinib 0.576245	como los costos 0.539059 seguro médico 0.533808 Cancer Center 0.605302 MD Anderson Cancer 0.572606 tratamiento inscribirán 0.618222 sk crizotinib 0.541473 cabo estudios 0.534561 Caris Life Sciences 0.579205 Investigación Oncológica ECOG-ACRIN 0.571301 Memorial Sloan-Kettering 0.625566 egfr mut afatinib 0.573282 NRG Oncology Group 0.568484 Iniciativa de Medicina 0.538366 Life Sciences identificarán 0.57351	CLICK HERE
4329	National Cancer Institute	Html	en	Cancer Screening	A summary of the benefits and possible harms of cancer screening tests.	time symptoms 0.320649 abnormal tissue 0.346264 False-negative test results 0.440391 screening tests 0.953871 false reassurance 0.328265 potential harms 0.743558 different cancer screening 0.573019 medical care 0.312433	people 0.200595 Early detection 0.319119 additional tests 0.299571 health problems 0.324983 doctors 0.208104 False-positive test results 0.450006 cancer 0.861445	CLICK HERE
14600	National Cancer Institute	Html	es	Tratamiento de los tumores vasculares infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores vasculares infantiles.	Natl Acad Sci 0.324634 anomalías vasculares retinianas 0.33309 hemangiomas is directly 0.365854 lesiones benignas 0.319493 Infants With Infantile 0.316042 lesiones precursoras 0.322133 frecuencia cardíaca 0.363288 cells from hemangiomas 0.365897 Denise Adams 0.34719 Ampliar Figura 0.334799 hemangiomas perioculares subcutáneos 0.383239 propranolol quizás 0.334782 Prospective study 0.315057 capillary hemangioma 0.369091 International Society 0.348608 vasculares hepáticos benignos 0.326723 tumores vasculares benignos 0.402681 Léauté-Labrèze C 0.314686 evaluación cardíaca 0.323474 angiofibromas nasofaríngeos 0.342724 síndrome phace 0.577507 angiofibroma nasofaríngeo 0.314735 anomalías renales 0.316886 Children With Infantile 0.315749 oral propranolol 0.362065	Clin Invest 0.327186 hemangiomas congénitos 0.761656 endothelial cells 0.315693 hemangiomas cutáneos 0.372477 Arch Dermatol 0.329954 Cuadro clínico 0.393896 Proc Natl Acad 0.325302 infantile hemangiomas 0.938164 With Infantile Hemangioma 0.438965 Nadolol Versus Propranolol 0.33549 vías respiratorias 0.521847 granuloma piógeno 0.329351 Vascular Anomalies Classification 0.319289 insuficiencia cardíaca transitoria 0.335633 antecedentes familiares 0.32937 hemangioma cutáneo congénito 0.383839 Complicated Vascular Anomalies 0.316136 Benigno Hemangioma 0.393265 Drolet BA 0.324986 lesiones cutáneas 0.338858 clasificación issva 0.316546 Blei F 0.314967 hemangioma epitelioide 0.552561 Hoeger P 0.315823	CLICK HERE
15802	National Cancer Institute	Html	null	About the Blue Ribbon Panel	Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.			CLICK HERE